Product Name |
MF |
CAS |
Details |
(R)-bis((R)-1-phenylethyl)amine |
C16H20ClN |
82398-30-9 |
|
2-chloroH-imidazo[1,2-a]pyridine |
|
0/1/99 |
|
Zanubrutinib impurity-13 |
|
|
|
5-methoxypyridine-2-carbonitrile |
C7H6N2O |
89809-63-2 |
|
2-(2-phenylacetyl)benzoic acid |
C15H13NO3 |
28565-98-2 |
|
4-methyl-2-oxo pentanoic acid |
C6H10O3 |
816-66-0 |
|
4-(chloromethyl)pentanoyl chloride |
C5H8Cl2O |
63480-12-6 |
|
6-Amino indazole |
C7H7N3 |
6967-12-0 |
|
6-Amino indazole |
C7H7N3 |
6967-12-0 |
|
1-phenylbutan-2-one |
C10H12O |
1007-32-5 |
|
1-phenylbutan-2-one |
C10H12O |
1007-32-5 |
|
(Z)-(2-ethoxy-2-((trimethylsilyl)oxy)vinyl)trimethylsilane |
C10H24O2Si2 |
65946-56-7 |
|
3,5-dibromopyrazin-2-amine |
C4H3Br2N3 |
24241-18-7 |
|
2-Amino-3,5-dibromopyrazine |
C4H3Br2N3 |
24241-18-7 |
|
2,2-bis(((2-bromo-2-methylpropanoyl)oxy)methyl)propane-1,3-diyl bis(2-bromo-2-methylpropanoate) |
C21H32Br4O8 |
243991-62-0 |
|
4-(4-(4-(4-aminophenylsulfonyl)phenoxy)phenylsulfonyl)benzenamine (Dapsone impurity) |
C24H20N2O5S2 |
54616-64-7 |
|
4-(4-(4-(4-aminophenylsulfonyl)phenoxy)phenylsulfonyl)benzenamine (Dapsone impurity) |
C24H20N2O5S2 |
54616-64-7 |
|
2-amino-4-bromo-3-fluorobenzoic acid |
C7H5BrFNO2 |
1416013-62-1 |
|
2-amino-4-bromo-3-fluorobenzoic acid |
C7H5BrFNO2 |
1416013-62-1 |
|
4-(6-(2-chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4',5':5,6]benzo[1,2-b][1,4]thiazin-2-yl)butanoic acid |
C16H20ClN3O2S |
191939-34-1 |
|
4,5-bis(2-chloroethyl)-1,3-dioxolan-2-one |
C5H4Cl2O3 |
1443544-27-1 |
|
N,N-diethyl-4-methylpiperazine-1-carboxamide |
C16H29N3O8 |
1642-54-2 |
|
4-(N-(2-hydroxyethyl)-N-methylamino)benzaldehyde |
C10H13NO2 |
1201-91-8 |
|
4-((2-Hydroxyethyl)(methyl)amino)benzaldehyde |
C10H13NO2 |
1201-91-8 |
|
Zanubrutinib impurity-10 |
C29H33N5O3 |
2190506-56-8 |
|
Zanubrutinib impurity-3 |
C29H33N5O3 |
2190506-56-8 |
|
Zanubrutinib impurity-3 |
C29H33N5O3 |
2190506-56-8 |
|
ethyl 2-oxopyrrolidine-3-carboxylate |
C7H11NO3 |
36821-26-1 |
|
ethyl 2-oxopyrrolidine-3-carboxylate |
C7H11NO3 |
36821-26-1 |
|
2-(benzyloxy)ethanesulfonamide |
C9H13NO3S |
881407-21-2 |
|
9-methoxynonan-1-ol |
C10H22O |
7289-51-2 |
|
1-(bromomethyl)-4-isopropylbenzene |
C10H13Br |
73789-86-3 |
|
1-(Bromomethyl)-4-isopropylbenzene |
C10H13Br |
73789-86-3 |
|
Densyl chloride |
C12H12ClNO2S |
605-65-2 |
|
(2R,3R)-diethyl oxirane-2,3-di corboxylate |
C8H12O5 |
74243-85-9 |
|
5-(ethoxymethyl)furan-2-carbaldehyde |
C8H10O3 |
1917-65-3 |
|
5-(ethoxymethyl)furan-2-carbaldehyde |
C8H10O3 |
1917-65-3 |
|
imidazo[1,2-b]pyridazine |
C17H17N3O |
146233-39-8 |
|
2-(8-bromo-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)ethanol |
|
|
|
Furan-2-yl(piperazin-1-yl)methanone hydrochloride |
C9H13ClN2O2 |
60548-09-6 |
|
3-morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)pyridin-2(1H)-one |
C20H25N3O3 |
545445-44-1 |
|
3-morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)pyridin-2(1H)-one |
C20H25N3O3 |
545445-44-1 |
|
Zanubrutinib impurity-5 |
C16H12N4O |
330792-70-6 |
|
5-amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile |
C16H12N4O |
330792-70-6 |
|
Zanubrutinib impurity-5 |
C16H12N4O |
330792-70-6 |
|
Zanubrutinib impurity-8 |
C16H12N4O |
330792-70-6 |
|
Zanubrutinib KSM-II : (4-isocyano-3-(4-phenoxyphenyl)-1H-pyrazol-5-amine) |
C16H12N4O |
330792-70-6 |
|
5-amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile |
C16H12N4O |
330792-70-6 |
|
2-Amino-5-cyano-N,3-dimethylbenzamide |
C10H11N3O |
890707-29-6 |
|
2-amino-5-cyano-N,3-dimethylbenzamide |
C10H11N3O |
890707-29-6 |
|
di-tert-butylsulfane |
C8H18S2 |
110-06-5 |
|
4-methylenepiperidine hydrochloride |
C6H12ClN |
144230-50-2 |
|
(R)-tetrahydrofuran-3-yl 4-methylbenzenesulfonate |
C11H14O4S |
219823-47-9 |
|
2,5-dimethoxybenzaldehyde |
C9H10O3 |
93-02-7 |
|
2,5-dimethoxybenzaldehyde |
C9H10O3 |
93-02-7 |
|
1-(3,5-dimethoxyphenyl)piperazine hydrochloride |
C12H18N2O2 |
53557-93-0 |
|
[1,1'-biphenyl]-2-ylmethanol |
C13H12O |
2928-43-0 |
|
tert-butyl ethyl(2-oxoethyl)carbamate |
C7H14N2O3 |
35150-09-5 |
|
Zanubrutinib impurity-4 |
C29H29N5O3 |
2190506-55-7 |
|
tert-butyl 4-(3-cyano-4,5,6,7-tetrahydro-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate |
C29H29N5O3 |
2190506-55-7 |
|
Zanubrutinib impurity-9 |
C29H29N5O3 |
2190506-55-7 |
|
tert-butyl 4-(3-cyano-4,5,6,7-tetrahydro-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate |
C29H29N5O3 |
2190506-55-7 |
|
Zanubrutinib KSM-III: (tert-butyl 4-(3-cyano-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate) |
C29H29N5O3 |
2190506-55-7 |
|
Zanubrutinib impurity-4 |
C29H29N5O3 |
2190506-55-7 |
|
Tetradecanamide |
C14H29NO |
638-58-4 |
|
Zanubrutinib impurity-1 |
C24H27N5O2 |
1633352-71-2 |
|
Zanubrutinib impurity-1 |
C24H27N5O2 |
1633352-71-2 |
|
3-amino-2-methylbenzoic acid |
C8H9NO2 |
52130-17-3 |
|
5-(hydroxymethyl)
pyrimidine-2,4(1H,3H)-dione |
C5H6N2O3 |
4433-40-3 |
|
thiazol-5-ylmethyl (5-((S)-2-amino-4-morpholinobutanamido)-1,6-diphenylhexan-2-yl)carbamate |
|
|
|
2-(3-bromo-4-cyclohexylphenyl)ethanol |
|
1898038-55-5 |
|
2-(3-bromo-4-cyclohexylphenyl)ethanol |
|
1898038-55-5 |
|
5-((E)-2-bromovinyl)pyrimidine |
C6H5BrN2O2 |
69304-49-0 |
|
1,10-diiododecane |
C10H20I2 |
16355-92-3 |
|
N'-(2-amino-6-chloro-5-formylpyrimidin-4-yl)furan-2-carbohydrazide |
C10H8ClN5O3 |
377729-80-1 |
|
chlorodimethyl(4-vinylphenyl)silane |
C10H13ClSi |
1009-44-5 |
|
2,3-dibromopropan-1-ol |
C3H6Br2O |
96-13-9 |
|
Zanubrutinib impurity-12 |
C27H29N5O3 |
1691249-44-1 |
|
2,3-Dimercaptopropan-1-ol |
C3H8OS2 |
59-52-9 |
|
methyl 3-amino-2-methylbenzoate |
C9H11NO2 |
18583-89-6 |
|
Zanubrutinib impurity-7 |
C12H21NO3 |
206989-61-9 |
|
Zanubrutinib impurity-7 |
C12H21NO3 |
206989-61-9 |
|
1,4,7,10-tetrabenzyl-1,4,7,10-tetraazacyclododecane |
C36H44N4 |
18084-64-5 |
|
1,4,7,10-Tetrabenzyl-1,4,7,10-tetraazacyclododecane, 97% |
C36H44N4 |
18084-64-5 |
|
furan-2-carbohydrazide |
C5H6N2O2 |
3326-71-4 |
|
methyl 2-(2-phenylacetyl)benzoate |
|
|
|
4,5-difluorobenzene-1,2-dioic acid |
C8H4F2O4 |
18959-31-4 |
|
2-(ethylthio)-tetrahydro-6-(hydroxymethyl)-2H-pyran-3,4,5-triol |
|
|
|
1H-indazole-3-carboxylic acid |
C8H6N2O2 |
4498-67-3 |
|
1H-indazole-3-carboxylic acid |
C8H6N2O2 |
4498-67-3 |
|
1H-indazole-3-carboxylic acid |
C8H6N2O2 |
4498-67-3 |
|
ethyl 2-((4-(3-((4-fluorophenyl)(hydroxy)methyl)-4-hydroxyphenoxy)-3,5-dimethylphenyl)amino)-2-oxoacetate (Axitirome) |
C25H24FNO6 |
156740-57-7 |
|
Torsemide Carboxylic Acid |
C16H18N4O5S |
113844-99-8 |
|
Torsemide Carboxylic Acid |
C16H18N4O5S |
113844-99-8 |
|
(R)-dihydro-4-propylfuran-2(3H)-one |
C7H12O2 |
63095-51-2 |
|
(R)-4-propyldihydrofuran-2(3H)-one |
C7H12O2 |
63095-51-2 |
|
1,6-dichloroisoquinoline |
C9H5Cl2N |
630421-73-7 |
|
3,6-dichlorobenzene-1,2-dithiol |
C6H4Cl2S2 |
87314-49-6 |
|
3,6-dichlorobenzene-1,2-dithiol |
C6H4Cl2S2 |
87314-49-6 |
|
3,6-dichlorobenzene-1,2-dithiol |
C6H4Cl2S2 |
87314-49-6 |
|